Literature DB >> 28083688

[Idiopathic intracranial hypertension].

J Bäuerle1,2, K Egger3, A Harloff4.   

Abstract

This review describes the clinical findings as well as thes diagnostic and therapeutic options for idiopathic intracranial hypertension (pseudotumor cerebri). Furthermore, the pathophysiological concepts are discussed. Idiopathic intracranial hypertension is characterized by signs and symptoms of raised intracranial pressure with no established pathogenesis. Common symptoms include headaches, visual loss and pulsatile tinnitus. Treatment has two major goals: the alleviation of headaches and the preservation of vision. Weight loss and acetazolamide are the cornerstones in the treatment of the disorder. Drainage of cerebrospinal fluid, optic nerve sheath fenestration and stent angioplasty of a sinus stenosis can be employed in severe cases.

Entities:  

Keywords:  Acetazolamide; Headaches; Pathophyiologie; Pseudotumor cerebri; Pulsatile tinnitus

Mesh:

Substances:

Year:  2017        PMID: 28083688     DOI: 10.1007/s00115-016-0279-6

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  33 in total

1.  Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988-2002.

Authors:  William T Curry; William E Butler; Fred G Barker
Journal:  Neurosurgery       Date:  2005-07       Impact factor: 4.654

2.  Inflammatory and haemostatic markers in idiopathic intracranial hypertension.

Authors:  J Hannerz; J P Antovic; M Blombäck; G Edman; M Khademi; F Piehl
Journal:  J Intern Med       Date:  2011-09-21       Impact factor: 8.989

3.  Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.

Authors:  Michael Wall; Michael P McDermott; Karl D Kieburtz; James J Corbett; Steven E Feldon; Deborah I Friedman; David M Katz; John L Keltner; Eleanor B Schron; Mark J Kupersmith
Journal:  JAMA       Date:  2014 Apr 23-30       Impact factor: 56.272

4.  The idiopathic intracranial hypertension treatment trial: clinical profile at baseline.

Authors:  Michael Wall; Mark J Kupersmith; Karl D Kieburtz; James J Corbett; Steven E Feldon; Deborah I Friedman; David M Katz; John L Keltner; Eleanor B Schron; Michael P McDermott
Journal:  JAMA Neurol       Date:  2014-06       Impact factor: 18.302

5.  Cerebrospinal fluid hypersecretion in pseudotumor cerebri.

Authors:  J O Donaldson
Journal:  Trans Am Neurol Assoc       Date:  1979

6.  Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study.

Authors:  Alexandra J Sinclair; Michael A Burdon; Peter G Nightingale; Alexandra K Ball; Peter Good; Timothy D Matthews; Andrew Jacks; Mark Lawden; Carl E Clarke; Paul M Stewart; Elizabeth A Walker; Jeremy W Tomlinson; Saaeha Rauz
Journal:  BMJ       Date:  2010-07-07

Review 7.  Bariatric surgery for the treatment of idiopathic intracranial hypertension.

Authors:  Jared Fridley; Rod Foroozan; Vadim Sherman; Mary L Brandt; Daniel Yoshor
Journal:  J Neurosurg       Date:  2010-01-22       Impact factor: 5.115

8.  Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children.

Authors:  Deborah I Friedman; Grant T Liu; Kathleen B Digre
Journal:  Neurology       Date:  2013-08-21       Impact factor: 9.910

9.  Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension.

Authors:  Michael Wall; Julie Falardeau; William A Fletcher; Robert J Granadier; Byron L Lam; Reid A Longmuir; Anil D Patel; Beau B Bruce; Hua He; Michael P McDermott
Journal:  Neurology       Date:  2015-08-05       Impact factor: 9.910

10.  Reproducibility and accuracy of optic nerve sheath diameter assessment using ultrasound compared to magnetic resonance imaging.

Authors:  Jochen Bäuerle; Florian Schuchardt; Laure Schroeder; Karl Egger; Matthias Weigel; Andreas Harloff
Journal:  BMC Neurol       Date:  2013-12-01       Impact factor: 2.474

View more
  1 in total

1.  Longitudinal Volume Quantification of Deep Medullary Veins in Patients with Cerebral Venous Sinus Thrombosis : Venous Volume Assessment in Cerebral Venous Sinus Thrombosis Using SWI.

Authors:  A K Dempfle; A Harloff; F Schuchardt; J Bäuerle; S Yang; H Urbach; K Egger
Journal:  Clin Neuroradiol       Date:  2017-06-06       Impact factor: 3.649

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.